159 related articles for article (PubMed ID: 3892654)
1. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma cholecystokinin concentrations in exocrine pancreatic atrophy in the rat.
Fölsch UR; Schafmayer A; Ebert R; Becker HD; Creutzfeldt W
Digestion; 1984; 29(1):60-4. PubMed ID: 6373466
[TBL] [Abstract][Full Text] [Related]
3. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
Kotler DP; Tierney AR; Kral JG; Bjorntorp P
Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man.
Fölsch UR; Creutzfeldt W
Scand J Gastroenterol Suppl; 1985; 112():54-63. PubMed ID: 2409582
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Krause HP; Keup U; Puls W
Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
[TBL] [Abstract][Full Text] [Related]
6. Exocrine and endocrine pancreatic function in rats treated with alpha-glucosidase inhibitor (acarbose).
Otsuki M; Sakamoto C; Ohki A; Okabayashi Y; Yuu H; Maeda M; Baba S
Metabolism; 1983 Aug; 32(8):846-50. PubMed ID: 6191180
[TBL] [Abstract][Full Text] [Related]
7. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
[TBL] [Abstract][Full Text] [Related]
8. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat.
Goda T; Yamada K; Sugiyama M; Moriuchi S; Hosoya N
J Nutr Sci Vitaminol (Tokyo); 1982 Feb; 28(1):41-56. PubMed ID: 6212654
[TBL] [Abstract][Full Text] [Related]
9. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
10. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
Fölsch UR; Ebert R; Creutzfeldt W
Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
[TBL] [Abstract][Full Text] [Related]
11. Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice.
Juretić D; Bernik S; Cop L; Hadzija M; Petlevski R; Lukac-Bajalo J
J Anim Physiol Anim Nutr (Berl); 2003 Aug; 87(7-8):263-8. PubMed ID: 12864906
[TBL] [Abstract][Full Text] [Related]
12. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
[TBL] [Abstract][Full Text] [Related]
13. alpha-Glucosidase inhibition in obesity.
William-Olsson T
Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
[TBL] [Abstract][Full Text] [Related]
14. The effect of pancreatic acinar atrophy upon the concentration of vasoactive intestinal polypeptide, substance P, somatostatin and glucagon in the pancreas and gastrointestinal tract of the rat.
Ballmann M; Fölsch UR; Conlon JM
Digestion; 1985; 32(1):70-5. PubMed ID: 2410316
[TBL] [Abstract][Full Text] [Related]
15. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Human and Rat Sucrase and Maltase Activities To Assess Antiglycemic Potential: Optimization of the Assay Using Acarbose and Polyphenols.
Pyner A; Nyambe-Silavwe H; Williamson G
J Agric Food Chem; 2017 Oct; 65(39):8643-8651. PubMed ID: 28914528
[TBL] [Abstract][Full Text] [Related]
17. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Krause HP; Keup U; Thomas G; Puls W
Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
Zavaroni I; Reaven GM
Metabolism; 1981 Apr; 30(4):417-20. PubMed ID: 7010078
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
Geddes R; Taylor JA
Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
